Intracranial hypertension medical symptoms, etiology, and spectrum a cross-sectional study

https://doi.org/10.53730/ijhs.v6nS9.13877

Authors

  • Naeem Ul Haq Assistant Professor Neurosurgery Mardan Medical Complex, Mardan
  • Sahibzada Haseeb Ahmed Medical Officer Services Hospital Peshawar
  • Mian Iftikhar Ul Haq Assistant Professor Neurosurgery Hayatabad Medical Complex Peshawar
  • Musawer Khan Senior Registrar MTI Mardan Medical Complex, Mardan
  • Syed Nasir Shah Junior Registrar MTI Mardan Medical Complex, Mardan

Keywords:

hypertension, intracranial hypertension, etiology

Abstract

Objective: To examine intracranial hypertension patients' spectrum, clinical features, and etiologies. Study Design: A Cross-sectional study. Place and duration of study: In the Department of Neurosurgery MMC Mardan from January 2019 to July 2020. Methodology: We used specific selection criteria to reduce the pool of IH patients from 67 to 32. Statistics and frequency distributions explain patients' demographics, clinical traits, and underlying reasons. Results: According to statistics, females (n = 30; 82%) with ages ranging from 21 to 35 (n = 13; 36%) and obesity (n = 2; 9%) were over represented. The most common clinical sign was headache (n = 18; 69%). On the other hand, idiopathic intracranial pressure had the greatest occurrence (44%). Conclusion: Women between the ages of 21 and 35 who are overweight or pregnant have an increased risk of developing idiopathic intracranial hypertension (IH).

Downloads

Download data is not yet available.

References

Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD, et al. Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity. Ophthalmology. 2017; 124(5): 697- 700.

Mondragon J, Klovenski V. Pseudotumor Cerebri Treasure Island (FL): Stat Pearls Publishing; 2019.

Pai S, Sharma T, Gupta R. Idiopathic intracranial hypertension: Clinical profile and outcome. J ClinOphthalmol Res. 2016; 4: 25-9.

Ma Y, Leng X, Dong Y, Xu W, Cao X, Ji X, et al. Risk factors for intracranial atherosclerosis: A systematicreview and meta-analysis. Atherosclerosis. 2019; 281: 71-77.

Agraz D, Morgan LA, Jain SF, Suh DW. Clinical features of pediatric idiopathic intracranial hypertension. Clinical Ophthalmology 2019. 2019; 13: 881–886.

Dinallo S, Waseem M. Cushing Reflex Treasure Island: StatPearls Publishing; 2019.

Sundholm A, Burkill S, Sveinsson O, Piehl F, Bahmanyar S. Population-based incidence and clinicalcharacteristics of idiopathic intracranial hypertension. Acta Neurol Scand. 2017; 1–7.

Haq N, Hassan N, Ishaq M, Usman M. Surgical outcome of benign intracranial hypertensionimproved vision. Pakistan Journal of Neurological Sciences. 2016; 11(2).

Ali A, Temkin N, Barber J, Pridgeon J, Chaddock K, Dikmen S, et al. A clinical decision rule to predictintracranial hypertension in severe traumatic brain injury. J. Neurosurg. 2018; 131(2): 612-619.

Stevens S, McClelland C, Chen J, Lee M. Idiopathic Intracranial Hypertension in a Mother and Pre-pubertalTwins. Neuroophthalmology. 2019; 43(1): 49-52.

Ananth JV, Sudharshan S, Selvakumar A, Devaleenal B, Kalaivani K, Biswas J. Idiopathic intracranial hypertension associated with anemia, secondary to the antiretroviral drug in a human immunodeficiency virus-positive patient. Indian J Ophthalmol. 2018; 16: 66.

Pal A, Sengupta P, Biswas D, Sen C, Mukherjee A, Pal S. Pattern of Idiopathic Intracranial Hypertension inIndian Population. Ann Indian Acad Neurol. 2019; 22(1): 47-51.

Tan MG, Worley B, Kim WB, Hove MT, Becker J. Drug-Induced Intracranial Hypertension: A SystematicReview and Critical Assessment of Drug-Induced Causes. Am J Clin Dermatol. 2020; 21(2): 163-172.

Sharma S, Hashmi MF, Kumar A. Intracranial Hypertension. In StatPearls. Treasure Island: Stat Pearls Publishing; 2019.

Zanon E, Pasca S. Intracranial hemorrhage in children and adults with hemophilia A and B: a literaturereview of the last 20 years. Blood Transfus. 2019; 17(5): 378-384.

Mollan SP, Aguiar M, Evison F. The expanding burden of idiopathic intracranial hypertension. Eye. 2019;33: 478–485.

Lichtenberg I, Blackwood E, Gordon J. The prevalence of idiopathic intracranial hypertension and associated co-morbidities in central western New Wales (NSW). Journal of Neurology, Neurosurgery &Psychiatry. 2017; 88: e1.

Tan MG, Worley B, Kim WB, Hove MT, Becker J. Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes. Am J Clin Dermatol. 2020; 21(2): 163-172

Published

24-01-2023

How to Cite

Ul Haq, N., Ahmed, S. H., Ul Haq, M. I., Khan, M., & Shah, S. N. (2023). Intracranial hypertension medical symptoms, etiology, and spectrum a cross-sectional study. International Journal of Health Sciences, 6(S9), 4616–4622. https://doi.org/10.53730/ijhs.v6nS9.13877

Issue

Section

Peer Review Articles

Most read articles by the same author(s)